tirzepatide and colonoscopy Break for Colonoscopy, then reintroduce dosage. : r/Retatrutide Colonoscopy Prep and GLP-1 Agonists:

The Research Supporting Tirzepatide A 2022 study published in the New England Journal of Medicine (Jastreboff et al.) found that adults with obesity who received tirzepatide 15 mg lost an average of 20.9% of their body weight over 72 weeks, compared to 3.1% in the placebo group

Safety data for lipotropic formulations in pregnancy and breastfeeding is lacking

Diabetic neuropathy Peripheral neuropathy Up to 50% of diabetic patients develop peripheral neuropathy, a type of nerve damage that may result in pain, loss of sensation, and weakness, particularly in the lower extremities (67)

This approach optimizes fat metabolism while also boosting energy levels and supporting detoxification processes